While relatively specific autoantibodies - ANCAs with the two main sub-specificities anti-proteinase 3 (PR3) and anti-myeloperoxidase (MPO) - have some value in taking the diagnoses in AAV, disease activity and course cannot reliably be determined by laboratory tests. This evidence concerns the gene MPO and anti-neutrophil cytoplasmic antibody-associated vasculitis.